Skip to main content
Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
779.18
+19.32 (2.54%)
Mar 9, 2026, 3:29 PM EDT - Market open

Regeneron Pharmaceuticals Revenue

In the year 2025, Regeneron Pharmaceuticals had annual revenue of $14.34B with 0.99% growth. Regeneron Pharmaceuticals had revenue of $3.88B in the quarter ending December 31, 2025, with 2.51% growth.

Revenue (ttm)
$14.34B
Revenue Growth
+0.99%
P/S Ratio
5.55
Revenue / Employee
$930,753
Employees
15,410
Market Cap
79.96B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202514.34B140.90M0.99%
Dec 31, 202414.20B1.08B8.27%
Dec 31, 202313.12B944.30M7.76%
Dec 31, 202212.17B-3.90B-24.26%
Dec 31, 202116.07B7.57B89.14%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Vertex Pharmaceuticals 12.00B
BeOne Medicines AG 5.34B
Incyte 5.14B
argenx SE 4.25B
Alnylam Pharmaceuticals 3.71B
BioNTech SE 3.70B
Royalty Pharma 2.38B
Moderna 1.94B
Revenue Rankings

REGN News

More News